Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117092) titled 'The Improvement of Symptoms and Disease Progression of Osteoarthritis by Reverse Methylation Intervention: A Single-center, Double-blind, Placebo-controlled Randomized Trial' on Jan. 20.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Fourth Medical Center of the Chinese People's Liberation Army General Hospital
Condition:
Osteoarthritis of the Knee Joint
Intervention:
The inverse methylation intervention group:Take supplements that could inverse methylation
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-01
Target Sample Size: The inverse ...